LYNGEN BIOMED AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−280k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−18k kr).
LYNGEN BIOMED AS is registered as a limited company in Tromsø, Troms with organisation number 999034128. The business is classified under other captive investment companies (NACE 64.323). The company was incorporated in 2012. Registered share capital is NOK 30,000, divided into 3000 shares. The company's stated purpose is: “Drive virksomhet innenfor medisinsk arbeid og forskning. Virksomheten kan utøves av selskapet selv, av andre, av datterselskaper eller gjennom deltagelse i eller i samarbeid med andre selskaper. Samt investering i andre selskap.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −18,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns LYNGEN BIOMED AS?
LYNGEN BIOMED AS has 4 registered shareholders:
- SYLVI STENERSEN HOVDENAK 50.0%
- MAREN MARIE THODE IVERSEN 16.7%
- ELINE DJUPVIK LARSEN 16.7%
- JOHAN MARKUS JOHANSEN 16.7%
Which companies does LYNGEN BIOMED AS own?
LYNGEN BIOMED AS holds stakes in 2 companies:
- CHONDRO ENGINEERING AS 4.2%
- LYFSTONE AS 0.5%
Frequently asked questions about LYNGEN BIOMED AS
Who owns LYNGEN BIOMED AS?
SYLVI STENERSEN HOVDENAK is the largest registered owner, with 50.0%.
What is the revenue of LYNGEN BIOMED AS?
LYNGEN BIOMED AS had revenue of NOK 0 in 2025.
Who is the general manager of LYNGEN BIOMED AS?
Oddmund Johannes Johansen is registered as general manager of LYNGEN BIOMED AS.
Where is LYNGEN BIOMED AS based?
LYNGEN BIOMED AS has its business address in Tomasjord.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.